Latest News

Long-term melatonin use found to raise heart attack risk

Long-term use of melatonin supplements may be linked with a higher risk of heart failure, according to new research — but does that mean people taking it as a sleep aid should stop using it now? In a review of electronic medical records, thousands of adults who had chronic insomnia and took melatonin for a year or longer had a 90% higher chance of heart failure over the next five years, compared with participants who had the same health factors but didn’t take melatonin. Melatonin users were also more than three times as likely to be hospitalized for heart failure

Global vaccine, Unicef sign deal to cut malaria vaccine price

LONDON, Nov 24 (Reuters) – Global vaccine alliance Gavi and its partner Unicef will pay 25% less for a new malaria vaccine made by the Serum Institute of India within roughly a year’s time, allowing them to reach more children despite cuts in international aid. The deal will reduce the cost of the R21 vaccine to $2.99 a dose from around $4. Unicef buys the vaccines with funding from Gavi, a partnership that works with governments to immunize children in the world’s poorest countries. Gavi estimates the price drop will save $90 million, which can fund 30 million more doses

Indian shares set to track Asian peers higher on rising odds of US rate cut

Nov 24 (Reuters) – India’s benchmark stock indexes were poised to open higher on Monday and inch towards record highs, tracking gains in other Asian markets on rising expectations of a December rate cut by the Federal Reserve. The Gift Nifty futures were trading at 26,159, as of 07:40 a.m. IST, indicating that the Nifty 50 could open above Friday’s close of 26,068.15. Both the Nifty and the Sensex logged second straight weekly gains on Friday on an improving earnings outlook and stable flows, trading less than 1% below their record highs touched in September 2024. Other Asian markets opened

Indian rupee at risk of steeper losses, bonds to react to liquidity and growth data

MUMBAI, Nov 24 (Reuters) – The Indian rupee is likely to face further depreciation pressure this week, with traders eyeing a move toward 90 per U.S. dollar in the absence of firm central bank intervention, while bond yields will track liquidity movements and local growth data. The rupee slumped to a record low of 89.49 per dollar on Friday, down 0.8% for the week. Get the latest news from India and how it matters to the world with the Reuters India File newsletter. Sign up here. A bout of portfolio outflows, uncertainty over a U.S.-India trade deal, and a pullback

1 … 456 457 458 459 460 … 1,488